This year, many governments issued documents supporting the development of gene therapy, cell therapy and gene editing

Kunming city

On August 16, 2022, the official website of Kunming Municipal People's Government officially released the "Kunming Cell Industry Development Plan (2021-2035)"

Henan Province

On August 8, 2022, the Henan Provincial Development and Reform Commission issued the Implementation Plan for Promoting the Development of the Bio-economy in Henan Province, which put forward the goal

Beijing

1.

2.

Shenzhen City

1.

2.

3.

Hunan Province

On July 15, 2022, the Hunan Provincial Drug Administration, the Hunan Provincial Health Commission, and the Hunan Provincial Department of Science and Technology issued a notice on strengthening the management of clinical research on cell therapy products (Hunan Drug Supervision and Development (2022) No.

Shanghai

1.

2.

Sichuan Province

On June 30, 2022, the Sichuan Provincial Drug Administration issued the "Several Measures on Further Promoting the Innovative Development of the Pharmaceutical Industry (Trial)" (hereinafter referred to as the "Measures") to provide policy support

Zhejiang Province

In June 2022, the General Office of the Zhejiang Provincial Government issued the Notice on the Action Plan for Promoting the High-quality Development of the Biomedical Industry (2022-2024

Jilin Province

On January 4, 2022, the General Office of the CPC Jilin Provincial Party Committee and the General Office of the People's Government of Jilin Province issued the Implementation Opinions on Accelerating the Construction of a Strong Pharmaceutical Province and Promoting the High-quality Development of the Pharmaceutical and Health Industry (hereinafter referred to as the "Implementation Opinions"), relying on the advantages of Jilin characteristic resources, focusing on accelerating the construction of the "Changliao Meitong Baiyan Pharmaceutical and Health Industry Corridor", and taking "large varieties, large projects, large enterprises and large agglomeration areas" as the starting point, and accelerating the formation of an industrial development pattern with excellent industrial layout, high agglomeration degree and strong industrial competitiveness To make the pharmaceutical and health industry in Jilin Province bigger and stronger, and to build Jilin into an influential northern medicine base

other

1.

Cell and Gene Therapy Workshop

2.

3.

4.
On April 20, 2022, the National Health Commission issued the "Clinical Application Management Specifications and Clinical Application Quality Control Indicators of Allogeneic Hematopoietic Stem Cell Transplantation Technology (2022 Edition)"
.

5.
In March 2022, the CPC Central Committee and the State Council issued the Opinions on Strengthening the Ethical Governance of Science and Technology, which is the first guiding document on the governance of science and technology ethics at the national level in China, and it is also another landmark event of China's scientific and technological ethics governance after the establishment of the National Science and Technology Ethics Committee, and the research and development of technology such as gene editing, xeno organ transplantation, and artificial intelligence will be further regulated
.

6.
On January 6, 2022, the State Drug Administration issued the "Good Manufacturing Practice for Drugs - Appendix to Cell Therapy Products" (Draft for Comments).

Source: official government website, public account "Cell and Gene Therapy Field"